(Q45855675)

17 December 2017

title

Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases (English)

1 reference

17 December 2017

0 references

1 reference

Xiaoping Duan

1

1 reference

17 December 2017

Shu-Fang Jia

series ordinal

2

1 reference

17 December 2017

Nadezhda Koshkina

series ordinal

3

1 reference

17 December 2017

Eugenie S Kleinerman

series ordinal

4

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

17 December 2017

published in

Cancer

1 reference

17 December 2017

volume

106

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

1382-1388

1 reference

17 December 2017

A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

Thymineless death in colon carcinoma cells is mediated via fas signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

Increased Fas expression reduces the metastatic potential of human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

Eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

Interleukin-12 enhances the sensitivity of human osteosarcoma cells to 4-hydroperoxycyclophosphamide by a mechanism involving the Fas/Fas-ligand pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

Effects of 4-hydroperoxy ifosfamide in combination with other anticancer agents on human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

Ifosfamide--pharmacology, safety and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

Induction of apoptosis by cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

inferred from DOI database lookup

7 January 2021

based on heuristic

Chemosensitivity of solid tumor cellsin vitro is related to activation of the CD95 system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21744

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.21744

1 reference

17 December 2017

1 reference

17 December 2017